Cillóniz, CatiaIelpo, AntonellaTorres Martí, Antoni2019-11-122019-11-122018-09-101523-3847https://hdl.handle.net/2445/144560Purpose of Review: This article reviews the most recent publications on community-acquired pneumonia (CAP) in the HIV-infected population on antiretroviral therapy (ART), focusing on epidemiology, prognostic factors, etiology, and antimicrobial therapy. The data discussed here were mainly obtained from a non-systematic review using Medline and references from relevant articles. Recent Findings: CAP remains a major cause of morbidity and mortality among HIV-infected patients and incurs high health costs despite the introduction of ART. Summary: HIV-infected patients are generally known to be more susceptible to bacterial pneumonia. Streptococcus pneumoniae is the most frequently reported pathogen in HIV-infected patients on ART, who present a higher rate of bacteremia than non-HIV-infected patients. Several studies have also examined microbial etiology and prognostic factors of CAP in HIV-infected patients on ART. Despite the high rate of bacterial pneumonia in these patients, mortality rates are not higher than in patients without HIV infection.9 p.application/pdfeng(c) Springer Nature, 2018Pneumònia adquirida a la comunitatVIH (Virus)Community-acquired pneumoniaHIV (Viruses)info:eu-repo/semantics/article6867882019-11-12info:eu-repo/semantics/openAccess563548230203191